1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SCAM Biopharmaceutical Contract Manufacturing Market – By Product

1.3.2        SCAM Biopharmaceutical Contract Manufacturing Market – By Service

1.3.3        SCAM Biopharmaceutical Contract Manufacturing Market – By Source

1.3.4        SCAM Biopharmaceutical Contract Manufacturing Market – By Country

2.           SCAM Biopharmaceutical Contract Manufacturing Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SCAM Biopharmaceutical Contract Manufacturing – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        SCAM – PEST Analysis

4.3         Expert Opinion

5.           SCAM Biopharmaceuticals Contract Manufacturing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Outsourcing by Pharmaceutical Companies

5.1.2        Increasing Demand for Biologics

5.2         Market Restraints

5.2.1        Surge in Competition in Industry

5.3         Future Trends

5.3.1        Consolidation in Pharmaceutical CMO Industry

5.3.2        COVID-19 Pandemic

5.4         Impact Analysis

6.           Biopharmaceutical Contract Manufacturing Market – SCAM Analysis

6.1         SCAM Biopharmaceutical Contract Manufacturing Market Revenue Forecast and Analysis

7.           SCAM Biopharmaceuticals Contract Manufacturing Market Analysis – By Product

7.1         Overview

7.2         SCAM Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)

7.3         Biologics

7.3.1        Overview

7.3.2        Biologics: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          Monoclonal Antibodies

7.3.2.1.1          Overview

7.3.2.1.2          Monoclonal Antibodies: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.2          Recombinant Proteins

7.3.2.2.1          Overview

7.3.2.2.2          Recombinant Proteins: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.3          Vaccines

7.3.2.3.1          Overview

7.3.2.3.2          Vaccines: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.3.2.4          Others

7.3.2.4.1          Overview

7.3.2.4.2          Others: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Biosimilar

7.4.1        Overview

7.4.2        Biosimilar: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.           SCAM Biopharmaceuticals Contract Manufacturing Market – By Service

8.1         Overview

8.2         SCAM Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)

8.3         Process Development

8.3.1        Overview

8.3.2        Process Development: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1          Downstream Processing

8.3.2.1.1          Overview

8.3.2.1.2          Downstream Processing: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.2          Upstream Processing

8.3.2.2.1          Overview

8.3.2.2.2          Upstream Processing: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Fill and Finish Operations

8.4.1        Overview

8.4.2        Fill and Finish Operations: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Analytical and QC Studies

8.5.1        Overview

8.5.2        Analytical and QC Studies: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Packaging

8.6.1        Overview

8.6.2        Packaging: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

9.           SCAM Biopharmaceuticals Contract Manufacturing Market – By Source

9.1         Overview

9.2         SCAM Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)

9.3         Mammalian

9.3.1        Overview

9.3.2        Mammalian: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Microbial/Non-Mammalian-Based Biologics

9.4.1        Overview

9.4.2        Microbial/Non-Mammalian-Based Biologics: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

10.        SCAM Biopharmaceutical Contract Manufacturing Market – Country Analysis

10.1      SCAM: Biopharmaceutical Contract Manufacturing Market

10.1.1     Overview

10.1.3     SCAM: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

10.1.3.1       Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1.1       Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.1.2       Brazil: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.3.1.2.1     Brazil: Biologics Market, 2019-2028 (USD Million)

10.1.3.1.3       Brazil: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.3.1.3.1     Brazil: Process Development Market, 2019-2028 (USD Million)

10.1.3.1.4       Brazil: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.3.2       Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2.1       Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.2.2       Argentina: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.3.2.2.1     Argentina: Biologics Market, 2019-2028 (USD Million)

10.1.3.2.3       Argentina: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.3.2.3.1     Argentina: Process Development Market, 2019-2028 (USD Million)

10.1.3.2.4       Argentina: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

10.1.3.3       Rest of SCAM: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.3.1       Rest of SCAM: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

10.1.3.3.2       Rest of SCAM: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)

10.1.3.3.2.1     Rest of SCAM: Biologics Market, 2019-2028 (USD Million)

10.1.3.3.3       Rest of SCAM: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)

10.1.3.3.3.1     Rest of SCAM: Process Development Market, 2019-2028 (USD Million)

10.1.3.3.4       Rest of SCAM: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)

11.        Biopharmaceutical Contract Manufacturing Market – Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Boehringer Ingelheim International GmbH

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      THERMO FISHER SCIENTIFIC INC.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      General Electric Company

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      MERCK KGAA

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Lonza

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Samsung Biologics

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      AbbVie Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Ajinomoto Co. Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             SCAM Biopharmaceutical Contract Manufacturing Market –Revenue and Forecast to 2028 (US$ Million)

Table 2.             Brazil Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 3.             Brazil Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 4.             Brazil Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 5.             Brazil Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 6.             Brazil Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 7.             Argentina Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 8.             Argentina Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 9.             Argentina Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 10.          Argentina Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 11.          Argentina Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of SCAM Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of SCAM Biologics Market – Revenue and Forecast to 2028 (USD Million)

Table 14.          Rest of SCAM Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 15.          Rest of SCAM Process Development Market – Revenue and Forecast to 2028 (USD Million)

Table 16.          Rest of SCAM Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)

Table 17.          Organic Developments Done By Companies

Table 18.          Inorganic Developments Done By Companies

Table 19.          Glossary of Terms, SCAM Biopharmaceutical Contract Manufacturing Market

LIST OF FIGURES

Figure 1.           SCAM Biopharmaceutical Contract Manufacturing Market Segmentation

Figure 2.           SCAM Biopharmaceutical Contract Manufacturing Segmentation, By Country

Figure 3.           SCAM Biopharmaceutical Contract Manufacturing Market Overview

Figure 4.           Biologics Segment Held Largest Share Of Product In SCAM Biopharmaceutical Contract Manufacturing Market

Figure 5.           Brazil Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           SCAM PEST Analysis

Figure 7.           SCAM Biopharmaceutical Contract Manufacturing Market Impact Analysis of Drivers and Restraints

Figure 8.           SCAM Biopharmaceutical Contract Manufacturing Market – Revenue Forecast and Analysis – 2020 - 2028

Figure 9.           SCAM Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)

Figure 10.        Biologics: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Monoclonal Antibodies: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Recombinant Proteins: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Vaccines: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Others: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Biosimilar: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        SCAM Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)

Figure 17.        Process Development: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Downstream Processing: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Upstream Processing: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Fill and Finish Operations: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Analytical and QC Studies: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Packaging: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        SCAM Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)

Figure 24.        Mammalian: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Microbial/Non-Mammalian-Based Biologics: SCAM Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        SCAM: Biopharmaceutical Contract Manufacturing Market, by Key Country – Revenue (2021) (USD Million)

Figure 27.        SCAM: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)

Figure 28.        Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Rest of SCAM: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)